Paul Wang to Antineoplastic Agents
This is a "connection" page, showing publications Paul Wang has written about Antineoplastic Agents.
Connection Strength
0.826
-
Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010; 596:467-88.
Score: 0.208
-
Tan J, Li C, Wang Q, Li S, Chen S, Zhang J, Wang PC, Ren L, Liang XJ. A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity. Mol Pharm. 2018 04 02; 15(4):1724-1728.
Score: 0.092
-
Tuguntaev RG, Okeke CI, Xu J, Li C, Wang PC, Liang XJ. Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery. Curr Pharm Des. 2016; 22(19):2857-65.
Score: 0.079
-
Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2016 Feb; 12(2):269-86.
Score: 0.079
-
Zhao Y, Chen F, Pan Y, Li Z, Xue X, Okeke CI, Wang Y, Li C, Peng L, Wang PC, Ma X, Liang XJ. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. ACS Appl Mater Interfaces. 2015 Sep 02; 7(34):19295-305.
Score: 0.077
-
Zhang J, Li S, An FF, Liu J, Jin S, Zhang JC, Wang PC, Zhang X, Lee CS, Liang XJ. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale. 2015 Aug 28; 7(32):13503-10.
Score: 0.076
-
Meng J, Liu Y, Gao S, Lin S, Gu X, Pomper MG, Wang PC, Shan L. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression. Cancer Biol Ther. 2015; 16(12):1764-74.
Score: 0.074
-
Xue X, Hall MD, Zhang Q, Wang PC, Gottesman MM, Liang XJ. Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking. ACS Nano. 2013 Dec 23; 7(12):10452-64.
Score: 0.068
-
Xue X, You S, Zhang Q, Wu Y, Zou GZ, Wang PC, Zhao YL, Xu Y, Jia L, Zhang X, Liang XJ. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. Mol Pharm. 2012 Mar 05; 9(3):634-44.
Score: 0.060
-
Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, Wang PC, Zhao Y, Gao X, Sun B, Chen C, Xing G, Shen D, Gottesman MM, Wu Y, Yin JJ, Jia L. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7449-54.
Score: 0.013